Physician profile
Christopher G Haddock
NPI 1841239555
$3,265.96
in general payments reported to CMS, 2019-2025
38 companies · $580 in 2025
The $580 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $260 · 2021: $349 · 2022: $366 · 2023: $662 · 2024: $524 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,765.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $421.68 | 2021-2025 | |
| Lilly USA, LLC | $350.65 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $327.73 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $318.11 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $271.21 | 2019-2025 | Airsupra, Breztri |
| Sanofi-Aventis U.S. LLC | $149.30 | 2019-2023 | |
| Amgen INC. | $148.93 | 2019-2025 | Evenity, Prolia, Prolia |
| Takeda Pharmaceuticals U.S.A., INC. | $133.73 | 2020-2022 | |
| Dexcom, INC. | $109.77 | 2024-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $99.25 | 2019-2025 | Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.66 | 2019-2022 | |
| Exact Sciences Corporation | $63.61 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Otsuka America Pharmaceutical, INC. | $58.42 | 2021-2023 | Rexulti |
| Idorsia Pharmaceuticals US INC | $46.42 | 2023 | Quviviq |
| Antares Pharma, INC. | $46.25 | 2024 | Xyosted |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Haddock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.